Labcorp Drug Development

Corporate History

Corning Life Sciences to Covance to Labcorp Drug Development

The nonclinical testing business inside today's Labcorp traces a convoluted lineage through multiple corporate identities. Covance originated as Corning Life Sciences, the pharmaceutical services arm of Corning Inc., before being spun off as an independent publicly traded company in 1996-97. For nearly two decades Covance operated as one of the world's largest CROs, building a global network of preclinical and clinical testing facilities.

Post-spin, Labcorp reports two segments: Diagnostics Laboratories (~78% of revenue) and Biopharma Laboratory Services (BLS, ~22%). BLS encompasses Central Laboratories and Early Development Research Laboratories — the latter is the bucket most relevant to toxicology, safety pharmacology, and animal research. For 2024, BLS revenue was $2.92B with a 15.7% operating margin.

Key People

Beagle Operations

Testing facilities, breeding operations, and documented scale

Madison, Wisconsin — Primary Dog Testing Facility

The Madison facility (USDA registration 35-R-0030, 3301 Kinsman Boulevard, Madison, WI 53704) is the best-documented dog-testing site in the Covance/Labcorp orbit. USDA annual reports confirm continuity of the registration number across the Covance-to-Labcorp transition, with the reporting entity name changing from “Covance Laboratories Inc” (FY2017) to “Labcorp Early Development Laboratories Inc” (FY2023).

Between FY2017 and FY2023, the site's reported dog “held/bred” inventory (Column B) dropped from 484 to 0, while dogs used decreased from 4,226 to 2,758. This is consistent with a shift away from maintaining dogs on-site while continuing to use dogs in studies — likely procured from external suppliers. A Wisconsin investigative outlet reported that the Madison branch “had 3,953 dogs in 2013,” citing USDA annual reports. The most supportable conclusion from USDA reporting alone is restructuring and downsizing of on-site dog holding, not full closure of dog work.

Other Confirmed Nonclinical Sites

A third-party lab index (ARLO / Rise for Animals) treats “Labcorp Early Development Laboratories Inc (formerly Covance)” as a multi-site complex and lists linked labs across NJ, CA, IN, MI, PA, and other states associated with APHIS number 35-R-0030, suggesting dog studies may occur across multiple affiliated sites.

Cumberland, Virginia — Beagle Breeding (Covance Research Products)

The facility at 482 Frenchs Store Road, Cumberland, VA 23040 operated as Covance Research Products, Inc. — a purpose-bred beagle supply operation. Multiple peer-reviewed papers cite this facility as the source of beagles used in studies. A Japanese government (MAFF) facility list confirms the name change from “Covance Research Products, Inc. Virginia Facility” to Envigo RMS LLC at the same address. A local environmental permitting notice also lists Covance Research Products at this address.

On June 3, 2019, Envigo acquired Labcorp's Covance Research Products business, including this facility. The site later became the subject of the federal civil complaint United States v. Envigo, documenting extensive USDA violations during 2021-2022 inspections under Envigo's ownership (18 provisions cited July 2021; 13 in October 2021; 26 in November 2021; 5 in March 2022).

Documented Beagle Study Modalities

Investigation Findings & Violations

USDA enforcement, undercover investigations, and regulatory actions

Vienna, VA — USDA Settlement (Case VA05018-AC)

Cumberland, VA — Covance-Era Inspection (2017)

Madison, WI — Inspection Record

A USDA inspection excerpt for the Madison site is embedded within an SEC-filed shareholder proposal correspondence packet. The excerpt cites a housekeeping/sanitation requirement (CFR 3.84) after inspectors observed conditions where nonhuman primates could reach objects not intended for animal contact. Complete Madison inspection coverage across all years was not retrieved in this research.

Undercover Investigations & Protest History

The Covance Name Problem

The Covance brand accumulated decades of protest, investigation, and reputational damage spanning three continents before Labcorp retired it. The 2005 UK High Court litigation expressly discussed reputational harm arguments. European Parliament records document license withdrawal proceedings. UK parliamentary debates documented community harassment campaigns around Covance facilities.

Labcorp's official rationale for the 2020-21 rebrand was “brand unification” — associating business unit brands with the Labcorp name. The company did not reference animal-rights campaigns in its public branding communications.

Regulatory & Policy Context

Labcorp is an Associate Member of the Association of Clinical Research Organizations (ACRO). Covance/Fortrea leadership has held ACRO leadership roles, including CEO chairmanship. Labcorp publishes a governance policy describing board-committee oversight of lobbying activities and political contributions. Federal lobbying disclosures exist under “Laboratory Corporation of America Holdings.”

Timeline

Sources